Serum is a potent stimulator of keratinocyte tissue plasminogen activator expression

Journal of Investigative Dermatology

Volumn 106, Issue 2, 1996, Pages 238-242

  Chen, Chih Shan Jason ^a   Jensen, Pamela J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFANT; KERATINOCYTE; MALE; NORMAL HUMAN; PEMPHIGOID; PEMPHIGUS; PRIORITY JOURNAL; PSORIASIS;

EID: 9044243756     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12340609     Document Type: Article

References (23)

1. Pollamen J, Stephens RW, Vahari A: Directed plasminogen activation at the surface of normal and malignant cells. Adv Cancer Res 57:273-328, 1991
2. Vassalli J-D, Sappino A-P, Belin D: The plasminogen activator/plasmin system. J Clin Invest 88:1067-1072, 1991
3. Isseroff RR, Rifkin DB: Plasminogen is present in the basal layer of epidermis. J Invest Dermatol 80:297-299, 1983
4. Jensen PJ, John M, Baird J: Urokinase and tissue type plasminogen activators in human keratinocyte culture. Exp Cell Res 187:162-169, 1990
5. Jensen PJ, Baird J, Morioka S, Lessin S, Lazarus GS: Epidermal plasminogen activator is abnormal in cutaneous lesions. J Invest Dermatol 90:777-782, 1988
6. Baird J, Lazarus GS, Belin D, Vassalli J-D, Busso N, Gubler P, Jensen PJ: mRNA for tissue-type plasminogen activator is present in lesional epidermisfrom patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis. J Invest Dermatol 95:548-532, 1990
7. Grøndahl-Hansen J, Nielsen LS, Kristensen P, Grøndahl-Hansen V, Andreasen PA, Danø K: Plasminogen activator in psoriatic scales is of the tissue-type as identified by monoclonal antibodies. Br J Dermatol 113:257-263, 1985
8. Spiers EM, Lazarus GS, Lyons-Giordano B: Expression of plasminogen activator enzymes in psoriatic epidermis. J Invest Dermatol 102:333-338, 1994
9. Grøndahl-Hansen J, Ralfkiaer E, Nielsen LS, Kristensen P, Frentz G, Danø K: Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin. J Invest Dermatol 88:28-32, 1987
10. Ando Y, Lazarus GS, Jensen PJ: Activation of protein kinase C inhibits human keratinocyte migration. J Cell Physiol 156:487-496, 1993
11. Jensen PJ, Wu Q, Janowitz P, Ando Y, Schechter NM: Plasminogen activator inhibitor type 2: an intracellular keratinocyte differentiation product that is incorporated into the cornified envelope. Exp Cell Res 217:65-71, 1995
12. Chen C-SJ, Lavker KM, Rodeck U, Risse B, Jensen PJ: Use of a serum-free epidermal culture model to show deleterious effects of epidermal growth factor on morphogenesis and differentiation. J Invest Dermatol 104:107-112, 1995
13. Tsao MC, Walthall BJ, Ham RG: Clonal growth of normal human epidermal keratinocytes in a defined medium. J Cell Physiol 110:219-229, 1982
14. Boyce ST, Ham RG: Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 81:33s-40s, 1983
15. Hashimoto K, Wun T-C, Baird J, Lazarus GS, Jensen PJ: Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention of pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor. J Invest Dertnatol 92:310-315, 1989
16. Gissler HM, Simon MM, Kramer MD: Enhanced association of plasminogen/plasmin with lesional epidermis of bullous pemphigoid. Br J Dermatol 127:272-277, 1992
17. Kramer MD, Reinartz J: The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/α2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin. J Clin Invest 92:978-983, 1993
18. Heutner EH, Jablonska S, Jarzabek-Chorzelska M, Marciejowska E, Rzesa G, Churzelski TP: Studies in immunodermatology 6. IF studies of autoantibodies to the stratum corneum and of in vivo fixed IgG in stratum corneum of psoriatic scales. Int Arch Allergy Appl Immunol 48:301-323, 1975
19. Verschoore M, Kowalewski C, Jarzabek-Chorzelska M, Bernard BA, Darmon YM: Intraepidermal leakage of plasma proteins after tape stripping of normal skin and uninvolved psoriatic skin. Br J Dermatol 122:391-397, 1990
20. Alkemade JAC, Molhuizen HOF, Ponec M, Kempenaar JA, Zeeuwen PLJM, de Jongh GJ, van Vlijmen-Willems IMJJ, van Erp PEJ, van de Kerkhof PCM, Schalkwijk J: SKALP/elafin is an inducible proteinase inhibitor in human epidermal keratinocytes. J Cell Sci 107:2335-2342, 1994
21. Schalkwijk J, van Vlijmen-Willems IMJJ, Alkemade JAC, de Jongh GJ: Immunohistochemical localization of SKALP/elafin in psoriatic epidermis. J Invest Dermatol 100:390-393, 1993
22. Chen C-S, Lyons-Giordano B, Lazarus GS, Jensen PJ: Differential expression of plasminogen activators and their inhibitors in an organotypic skin coculture system. J Cell Sci 1106:45-53, 1993
23. Grøndahl-Hansen J, Lund LR, Ralfkiaer E, Ottevanger V, Danø K: Urokinase-and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo. J Invest Dermatol 90:790-795, 1988